Por: Los Angeles Times Business June 03, 2023
Cancer screening outfit Grail said Friday that a software glitch at a third-party telemedicine vendor led to erroneous letters being sent to about 400 people warning that they may have developed cancer. Grail is owned by San Diego’s Illumina, the leader in DNA sequencing equipment. But Grail operates independently under orders from European anti-monopoly regulators, who have called for divestiture. So have U.S. regulators. The company is... + full article
The New York Times USA Business April 03, 2023
The Federal Trade Commission on Monday ordered Illumina, the leading maker of gene-sequencing machines, to divest Grail, a cancer-test developer.The move by the F.T.C. is the latest development in a case seen by antitrust experts as a to stop big companies from buying fledgling... + más
FTC orders Illumina to unwind $7B deal for cancer test developer Grail | Fox Business
Biotech company Illumina pushes back against Carl Icahn’s proxy fight over $7.1 billion Grail deal | CNBC
Fox Business USA Business April 03, 2023
Check out whats clicking on FoxBusiness.com The on Monday ordered life sciences company Illumina to unwind its $7.1 billion acquisition of cancer detection test developer Grail Inc., citing antitrust concerns. The commission voted unanimously in a 4-0 decision to force Illumina... + más
F.T.C. Orders Gene-Sequencing Company Illumina to Divest Acquisition | The New York Times
New York Post USA Life March 28, 2023
The future of cancer treatment — hailed as the “holy grail” of early detection — is now being put to the test. Following a radically successful trial on cancer patients, a new blood test that promises to predict tumors more than a year before they begin to form is now... + más
A New Approach to Spotting Tumors: Look for Their Microbes | The New York Times
CNBC USA Health March 24, 2023
In this articleCarl Icahn speaking at Delivering Alpha in New York on Sept. 13, 2016.David A. Grogan CNBCCarl Icahn on Friday alleged that 's directors demanded extra personal liability insurance before the biotech company signed off on a $7.1 billion acquisition of cancer... + más
Icahn proposes three candidates for Illumina’s board — Here’s what could be next in the battle | CNBC
CNBC USA Health March 21, 2023
In this articleCarl IcahnAdam Jeffery CNBC Biotech company pushed back Monday against Carl Icahn's proxy fight over the company's acquisition of cancer test developer Grail, saying the activist investor's board nominees do not add value. The San Diego-based DNA... + más
Carl Icahn claims Illumina directors got extra insurance to close 'disastrous' $7.1 billion Grail deal | CNBC
CNBC USA Business March 18, 2023
Business: develops, manufactures and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and Grail. Grail, which was acquired in , is a health-care company focused on early detection of... + más
Newsweek USA Nation November 28, 2022
Police in Idaho likely know more about the gruesome slayings of four University of Idaho students than they have revealed, a former police chief told Newsweek.The students were found dead in their beds in an off-campus rental house in Moscow on November 13. They were housemates... + más
Man charged in university student killings arrives in Idaho | The Boston Globe
Idaho murders: Suspect Bryan Kohberger arrives in Idaho to face charges | ABC News
About iurex | Privacy Policy | Disclaimer |